Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies DJ Stein, P Szatmari, W Gaebel, M Berk, E Vieta, M Maj, YA de Vries, ... BMC Medicine 18 (1), 1-24, 2020 | 239 | 2020 |
Reporting bias in clinical trials investigating the efficacy of second-generation antidepressants in the treatment of anxiety disorders: a report of 2 meta-analyses AM Roest, P de Jonge, CD Williams, YA de Vries, RA Schoevers, ... JAMA psychiatry 72 (5), 500-510, 2015 | 131 | 2015 |
Comorbidity within mental disorders: a comprehensive analysis based on 145 990 survey respondents from 27 countries JJ McGrath, CCW Lim, O Plana-Ripoll, Y Holtz, E Agerbo, NC Momen, ... Epidemiology and Psychiatric Sciences 29, 2020 | 104 | 2020 |
The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression YA De Vries, AM Roest, P De Jonge, P Cuijpers, MR Munafò, ... Psychological medicine 48 (15), 2453-2455, 2018 | 101 | 2018 |
Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression YA De Vries, P De Jonge, E van den Heuvel, EH Turner, AM Roest The British Journal of Psychiatry 208 (6), 515-521, 2016 | 64 | 2016 |
A many-analysts approach to the relation between religiosity and well-being S Hoogeveen, A Sarafoglou, B Aczel, Y Aditya, AJ Alayan, PJ Allen, ... Religion, Brain & Behavior, 1-47, 2022 | 59 | 2022 |
Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis YA de Vries, AM Roest, EH Bos, JGM Burgerhof, HM van Loo, P de Jonge The British Journal of Psychiatry 214 (1), 4-10, 2019 | 47 | 2019 |
Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials EH Turner, A Cipriani, TA Furukawa, G Salanti, YA de Vries PLoS medicine 19 (1), e1003886, 2022 | 45 | 2022 |
A comparison of DSM‐5 and DSM‐IV agoraphobia in the World Mental Health Surveys AM Roest, YA de Vries, CCW Lim, HU Wittchen, DJ Stein, T Adamowski, ... Depression and anxiety 36 (6), 499-510, 2019 | 43 | 2019 |
Citation bias and selective focus on positive findings in the literature on the serotonin transporter gene (5-HTTLPR), life stress and depression YA de Vries, AM Roest, M Franzen, MR Munafò, JA Bastiaansen Psychological Medicine 46 (14), 2971, 2016 | 39 | 2016 |
Childhood generalized specific phobia as an early marker of internalizing psychopathology across the lifespan: results from the World Mental Health Surveys YA De Vries, A Al-Hamzawi, J Alonso, G Borges, R Bruffaerts, B Bunting, ... BMC medicine 17 (1), 1-11, 2019 | 38 | 2019 |
Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: a meta-analysis YA de Vries, AM Roest, L Beijers, EH Turner, P de Jonge European Neuropsychopharmacology 26 (11), 1752-1759, 2016 | 38 | 2016 |
Citation distortions in the literature on the serotonin-transporter-linked polymorphic region and amygdala activation JA Bastiaansen, YA de Vries, MR Munafò Biological psychiatry 78 (8), E35-E36, 2015 | 36 | 2015 |
Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials AE DE WIT, YA DE VRIES, C SCHEPER, A FOKKEMA, CAH JANSSEN, ... American Journal of Obstetrics and Gynecology, 2021 | 34 | 2021 |
The antidepressant standoff: why it continues and how to resolve it J Ormel, P Spinhoven, YA de Vries, AOJ Cramer, GJ Siegle, ... Psychological medicine 50 (2), 177-186, 2020 | 29 | 2020 |
Patterns and correlates of patient‐reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys RC Kessler, AE Kazdin, S Aguilar‐Gaxiola, A Al‐Hamzawi, J Alonso, ... World Psychiatry 21 (2), 272-286, 2022 | 23 | 2022 |
Initial severity and antidepressant efficacy for anxiety disorders, obsessive‐compulsive disorder, and posttraumatic stress disorder: An individual patient data meta‐analysis YA de Vries, AM Roest, JGM Burgerhof, P de Jonge Depression and anxiety 35 (6), 515-522, 2018 | 22 | 2018 |
Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials YA De Vries, AM Roest, EH Turner, P De Jonge Psychological medicine 49 (12), 2020-2026, 2019 | 17 | 2019 |
Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose YA de Vries, P de Jonge, L Kalverdijk, JHJ Bos, CCM Schuiling-Veninga, ... European child & adolescent psychiatry 25 (11), 1161-1170, 2016 | 17 | 2016 |
Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys JOH Gmelin, YA De Vries, L Baams, S Aguilar-Gaxiola, J Alonso, ... Social psychiatry and psychiatric epidemiology 57 (11), 2319-2332, 2022 | 15 | 2022 |